BIIB241206P180000
- 22.12
- 0.000.00%
Biogen Newsroom
Super Micro Computer Teeters On Edge Of Nasdaq 100: Can XAI, Nvidia Help Stabilize Trajectory?
MicroStrategy Stock Could Get Added to the Nasdaq 100 Because of a Quirk
Market Climbs on CPI Inflation and Likelihood of Rate Cuts | Livestock
Biogen Reinstated With a Neutral at BofA
BofA Restarts Coverage of 11 Large-cap Biopharmas
Market Falls Wednesday, but Googles Chip Impresses | WST
Google's Quantum Chip Might Have Contacted Parallel Universes | Live Stock
B of A Securities Reinstates Neutral on Biogen, Announces $178 Price Target
Insider Sale: Head of Development of $BIIB (BIIB) Sells 110 Shares
Biogen Downgraded On Pipeline Setbacks And Leqembi Sales Slowdown
Biogen Cut at Jefferies as '2025 Has a Tough Setup'
Monday Market Falls, Chinese Stocks Climb, Indices Rebalance | Live Stock
This AMD Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Biogen Analyst Ratings
Jefferies Downgrades Biogen(BIIB.US) to Hold Rating, Cuts Target Price to $180
Biogen's Modest Growth Prospects and Revenue Challenges Highlighted in Hold Rating
Biogen Downgraded to Hold From Buy at Jefferies
Express News | Biogen : Jefferies Cuts to Hold From Buy
Biogen Appoints Tim Power as Head of Investor Relations
Stocks With Best Odds of Risk-adjusted Returns Deserve Attention: Goldman Sachs